[go: up one dir, main page]

UY27306A1 - SOFT ELASTIC CAPSULES AND COMPOSITIONS OF THE SAME - Google Patents

SOFT ELASTIC CAPSULES AND COMPOSITIONS OF THE SAME

Info

Publication number
UY27306A1
UY27306A1 UY27306A UY27306A UY27306A1 UY 27306 A1 UY27306 A1 UY 27306A1 UY 27306 A UY27306 A UY 27306A UY 27306 A UY27306 A UY 27306A UY 27306 A1 UY27306 A1 UY 27306A1
Authority
UY
Uruguay
Prior art keywords
soft elastic
compositions
same
elastic capsule
elastic capsules
Prior art date
Application number
UY27306A
Other languages
Spanish (es)
Inventor
Sergio Petriconi
Alessandro Barbato
Martin Urch
Roberta Scuppa
Azita S-Gerhardt
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY27306A1 publication Critical patent/UY27306A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una cápsula elástica blanda que contiene un agente farmacéutico o una mezcla de agentes farmacéuticos. La cápsula elástica blanda se prepara a partir de una composición de relleno y una composición de revestimiento que confiere características físicas aceptables a dicha cápsula elástica blanda cuando alcanza un estado de equilibrio. Los agentes farmacéuticos de la composición de relleno también son solubles cuando la cápsula elástica blanda está en el estado de equilibrio.A soft elastic capsule containing a pharmaceutical agent or a mixture of pharmaceutical agents. The soft elastic capsule is prepared from a filling composition and a coating composition that confers acceptable physical characteristics to said soft elastic capsule when it reaches an equilibrium state. The pharmaceutical agents of the filler composition are also soluble when the soft elastic capsule is in the steady state.

UY27306A 2001-05-25 2002-05-24 SOFT ELASTIC CAPSULES AND COMPOSITIONS OF THE SAME UY27306A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86628501A 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
UY27306A1 true UY27306A1 (en) 2002-12-31

Family

ID=25347294

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27306A UY27306A1 (en) 2001-05-25 2002-05-24 SOFT ELASTIC CAPSULES AND COMPOSITIONS OF THE SAME

Country Status (8)

Country Link
EP (1) EP1395249A1 (en)
JP (1) JP2005508294A (en)
AR (1) AR034995A1 (en)
CA (1) CA2448438A1 (en)
MX (1) MXPA03010771A (en)
PE (1) PE20030098A1 (en)
UY (1) UY27306A1 (en)
WO (1) WO2002096395A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60028754T2 (en) 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park SOLID DISPERSION WITH RITONAVIR, FENOFIBRATE OR GRISEOFULVIN
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CN104411300A (en) 2012-05-03 2015-03-11 希普拉有限公司 Antiretroviral composition
WO2019130341A1 (en) * 2017-12-26 2019-07-04 Hetero Labs Limited Capsule compositions comprising lopinavir and ritonavir
GB201917252D0 (en) 2019-11-27 2020-01-08 Pharmaceutic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232333B1 (en) * 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
HU229501B1 (en) * 1999-06-04 2014-01-28 Abbvie Inc Pharmaceutical formulations comprising an hiv protease inhibitor
US6608198B2 (en) * 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical

Also Published As

Publication number Publication date
EP1395249A1 (en) 2004-03-10
PE20030098A1 (en) 2003-02-12
WO2002096395A1 (en) 2002-12-05
CA2448438A1 (en) 2002-12-05
MXPA03010771A (en) 2004-07-01
AR034995A1 (en) 2004-04-14
JP2005508294A (en) 2005-03-31

Similar Documents

Publication Publication Date Title
BR9814229A (en) Cosmetic makeup
CO5840249A1 (en) PERSONAL LUBRICANT COMPOSITIONS AND EQUIPMENT TO PROVIDE PERSONAL LUBRICATION
BR9714270A (en) Liquid skin cleansing composition
PE20020968A1 (en) ZINC-FREE AND ZINC-POOR INSULIN PREPARATIONS, WITH IMPROVED STABILITY
EA200600598A1 (en) DOSAGE FORMS OF SLOW-DROP
AR022008A1 (en) A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR037490A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
DK1365749T3 (en) Process for the preparation of pharmaceutical compositions for use in soft gel formulations
WO2006003481A3 (en) Oleaginous pharmaceutical and cosmetic foam
AR002266A1 (en) PHARMACEUTICAL COMPOSITION OF SOFT GELATIN OR DOSAGE FORM THAT INCLUDES IT
DK1126828T3 (en) Oral administration of adenosine analogues
HUP9902454A2 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
BR0111678A (en) Medicinal compositions containing propenone derivatives
CO4940406A1 (en) QUICK-ACTION PARACETAMOL COMPOSITIONS
UY27306A1 (en) SOFT ELASTIC CAPSULES AND COMPOSITIONS OF THE SAME
ATE382356T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ESTETROL DERIVATIVES AND USE IN CANCER TREATMENT
PE20040324A1 (en) LIQUID LIQUID FORMULATIONS OF ENTECAVIR AND USE
DE60316714D1 (en) PHARMACEUTICAL FORMULATION CONTAINING OLANZAPINE
BRPI0510694A (en) pharmaceutical compositions comprising concentrated soft gelatin encapsulated active ingredients
AR002972A1 (en) PILLS THAT HAVE A PHARMACEUTICAL MATRIX THAT PROVIDE AN APPROPRIATE PROFILE OF DRUG RELEASE, COMPOSITION FOR THE PREPARATION OF SAID PILLS, PROCESS FOR PREPARING SUCH PILLS AND DOSAGE FORMS OF SUCH COMPOSITION.
ATE359248T1 (en) SMOKE GENERATING COMPOSITION
DE60119367D1 (en) CELLULOSE DERIVATIVE CAPSULE, SUCH AS, for example, HPMC, which contains BENZIMIDAZOLE DERIVAT. OMEPRAZOL
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
BRPI0412592A (en) stable pharmaceutical formulation
ES2136198T3 (en) RECTAL COMPOSITIONS CONTAINING ODANSETRON IN THE FORM OF ITS FREE BASE.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141126